Immunoadjuvant composition and use thereof
US8894996B2 · kind B2 · utility
3Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2010 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | Jan 14, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a composition comprising, as an active ingredient, at least one selected from the group consisting of a Zc3h12a gene inhibitor and a Zc3h12a protein inhibitor. This composition can be used as an immunoadjuvant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.